Intervention

Sodium-glucose cotransporter 2 inhibitor

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions5

Lead sponsors shown3

Clinical trials

3 shown

Effect of Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular Remodeling Among Diabetic and Non Diabetic Patients With Chronic Heart FailureNCT06137430 · 2023-12-01

Investigation of Biomarker Response to SGLT2 Inhibition in Heart FailureNCT06140251 · 2023-08-21

Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease RiskNCT05214573 · 2021-12-01

Common conditions

Cardiac Disease1 Chronic Heart Disease1 Heart Failure1 SGLT2 Inhibitiors Remodeling Effect1 Type 2 Diabetes1

Leading sponsors

Assiut University1 Mayo Clinic1 Queen's University, Belfast1

Trial status mix

UNKNOWN2

COMPLETED1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.